Integrating hepatitis C care into human immunodeficiency virus clinics in the direct-acting antiviral era: From biological disadvantage to structural opportunity

Figure 1 Conceptual shift in decision-making for human immunodeficiency virus/hepatitis C virus coinfection in the direct-acting antiviral era. Magnetic resonance elastography image adapted from Wu et al[34], see Supplementary material. HIV: Human immunodeficiency virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; CVD: Cardiovascular disease; DAA: Direct-acting antiviral; SVR: Sustained virologic response; AST: Aspartate aminotransferase; APRI: Aspartate aminotransferase to platelet ratio index.